Evaluation of antidiabetic potential of Co₃O₄ and TiO₂ nanoparticles on alloxan-induced diabetic mice

The worldwide well-being distress recognized as diabetes mellitus is categorized by the unregulated breakdown of glucose and its linked effects. In this work, the possibility of cobalt oxide (Co₃O₄) and titanium dioxide (TiO₂) nanoparticles (NPs) created by hydrothermal methods for the prevention of diabetes in mice using alloxan injections is examined. The NPs were characterized via XRD, SEM, EDX, and UV-vis spectrophotometry. For assessing the effect of treatment genes of the liver such as Glucokinase (GK), Protein kinase B (AKT), and immune-response (IR) were expressed via quantitative real-time PCR (qRT-PCR). In addition, histological inspection was carried out for the liver and spleen. Next, the anti-diabetic effect of the as-synthesized nanoparticles was examined. The trial, which assessed TiO₂ and Co₃O₄ NPs' potential to prevent diabetes in mice given alloxan, was skillfully carried out. Together with Glucophage, TiO₂ and Co₃O₄ NPs were shown to have higher levels of IR, GK, and AKT mRNA expression. As a consequence, the cells absorb glucose more readily. Since TiO₂ and Co₃O₄ nanoparticles may have hypoglycemic effects, further study is necessary to fully appreciate their potential as a practical and affordable diabetic therapy option. Toxicology, biologic compatibility, and the dependability of artificial nano-formulations are examples of possible study subjects.